Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00886132Phase 2Completed
A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
Adenoid Cystic CarcinomaSalivary Gland Cancer
Principalinvestigator
NCT01678105Phase 2Completed
A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands
ACCMetastatic Adenoid Cystic Carcinoma of the Salivary GlandsRecurrent Adenoid Cystic Carcinoma of the Salivary Glands+1 more
Principalinvestigator

Research Network

Collaboration Network

29 collaborators·29 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Moderately Similar
13 trials

Shared therapeutic areas:

ACCMetastatic Adenoid Cystic Carcinoma of the Salivary GlandsRecurrent Adenoid Cystic Carcinoma of the Salivary Glands+1 more

Worked with same sponsors:

Novartis PharmaceuticalsOntario Clinical Oncology Group (OCOG)
Collaborated on 1 trial
Similarity Score44%

Greg Pond, PhD

Ontario Clinical Oncology Group (OCOG)

Moderately Similar
1 trials

Shared therapeutic areas:

ACCMetastatic Adenoid Cystic Carcinoma of the Salivary GlandsRecurrent Adenoid Cystic Carcinoma of the Salivary Glands+1 more

Worked with same sponsors:

Novartis PharmaceuticalsOntario Clinical Oncology Group (OCOG)
Collaborated on 1 trial
Similarity Score44%

Alan Ho, MD, PhD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Carcinoma, Adenoid CysticCancer of Salivary Gland
Similarity Score12%

Jennifer Johnson, MD, PhD

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Related
5 trials

Shared therapeutic areas:

Carcinoma, Adenoid CysticCancer of Salivary Gland
Similarity Score12%

Vivek Subbiah, MD

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Carcinoma, Adenoid CysticCancer of Salivary Gland
Similarity Score12%

Renata Ferrarotto, MD

M.D. Anderson Cancer Center

Related
6 trials

Shared therapeutic areas:

Carcinoma, Adenoid CysticCancer of Salivary Gland
Similarity Score12%

Carla ML van Herpen, MD, PhD

Radboud University Medical Center

Related
2 trials

Shared therapeutic areas:

Cancer of Salivary GlandCarcinoma, Adenoid Cystic
Similarity Score12%

Charalampos Floudas, M.D.

National Cancer Institute (NCI)

Related
9 trials

Shared therapeutic areas:

Carcinoma, Adenoid CysticCancer of Salivary Gland
Similarity Score12%

Rajesh Belani, M.D.

Sponsor Executive Medical Director

Related
2 trials

Shared therapeutic areas:

Carcinoma, Adenoid CysticCancer of Salivary Gland
Similarity Score12%

Glenn J Hanna, MD

Dana-Farber Cancer Institute

Related
3 trials

Shared therapeutic areas:

Cancer of Salivary GlandCarcinoma, Adenoid Cystic
Similarity Score12%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00886132Phase 2PrincipalInvestigator

A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

Adenoid Cystic CarcinomaSalivary Gland Cancer
Completed
NCT01678105Phase 2PrincipalInvestigator

A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands

ACCMetastatic Adenoid Cystic Carcinoma of the Salivary GlandsRecurrent Adenoid Cystic Carcinoma of the Salivary Glands+1 more
Completed

All 2 trials loaded